Masimo MASI recently reported findings from the NeoPODS study, a large prospective real-world evaluation of its SET pulse oximetry technology in critically ill newborns. The study demonstrated less ...

Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...

This resource was independently developed by AJMC and funded by an Independent Medical Education Grant from DexCom, Inc. This actionable resource explores the rising need for continuous glucose ...

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose management in adults living with type 2 diabetes who are treated with basal ...

is a senior reporter and author of the Optimizer newsletter. She has more than 13 years of experience reporting on wearables, health tech, and more. Before coming to The Verge, she worked for Gizmodo ...

Continuous glucose monitoring (CGM) is no longer limited to type 1 diabetes (T1D) and may play a significant role in shaping the care of type 2 diabetes (T2D). Emerging evidence indicates that broader ...

Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared to those monitored using routine spot checks, a new study from Wake Forest ...

Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared to those monitored using routine spot checks, a new study from Wake Forest ...

Bridger Management sold 47,841 shares of Masimo in the fourth quarter. The move resulted in the quarter-end position value decreasing by $7.06 million. The position was previously 3.8% of fund AUM as ...

NEW ORLEANS, LA, UNITED STATES, March 20, 2026 /EINPresswire.com/ — Air quality monitoring has become an important component of environmental management around ...

In the near future, people will use AI-powered devices at home to scan their faces and bodies for health assessments. Credit: ChatGPT Every Wednesday and Friday, TechNode’s Briefing newsletter ...